This is the strength of Srotovibhanga. It does not replace medical diagnosis; it gives Ayurveda a way to understand why reproductive, metabolic, thyroid, digestive, and emotional symptoms often travel together. One patient may have Artavavaha Srotas disturbance in the menstrual-reproductive field, Rasavaha and Medovaha involvement in nourishment and metabolism, and Manovaha disturbance in mood, cognition, and emotional steadiness. The work of treatment is not to chase every label separately, but to identify the shared pattern of channel morbidity and correct it carefully.

The Classical Framework: What Srotovibhanga Actually Means

In Charaka Samhita, Sroto Vimana presents Srotas as channels of transport and transformation. The body is described as a network of visible and subtle pathways through which Dhatu, nourishment, wastes, impulses, and functional processes move. For clinical use, Charaka gives a practical framework of thirteen gross Srotas, while also acknowledging innumerable subtle channels throughout the body. When these channels are disturbed, disease develops according to the Srotas involved, the Dosha affecting it, the Dhatu being carried, and the form of Srotodushti present.

1. Atipravritti (excessive flow): A channel produces or releases too much of its content. The clinical image is overflow, hypersecretion, excessive discharge, or abnormal increase of function.
2. Sanga (obstruction): Flow is obstructed, slowed, or functionally reduced. This is the pattern of stagnation, congestion, heaviness, delayed output, impaired movement, and blocked transformation.
3. Siragranthi (nodule or knot formation): A channel develops a localized knot, swelling, cystic change, glandular enlargement, or mass-like expression. This is a more structural form of channel disturbance.
4. Vimarga gamana (misdirected flow): A substance or functional process moves in the wrong direction or appears in an improper pathway or site.

These four are not four fixed diseases. They are four patterns through which any channel can become disturbed. The same woman may show Sanga in one channel, Atipravritti in another, and Siragranthi where the disturbance has become more localized and structural.

Reading Women’s Health Through the Same Lens

Modern diagnoses such as PCOS, endometriosis, Hashimoto’s thyroiditis, thyroid nodules, fibroids, ovarian cysts, and depression should be respected as medical conditions requiring appropriate evaluation. The Ayurvedic task is not to rename them mechanically, but to ask: which Srotas is involved, is the flow excessive, obstructed, nodular, or misdirected, and what is the Dosha-Dhatu background?

PCOS: Artavavaha Srotas Sanga with Kapha-Meda and Apana Vata

In modern medicine, adult PCOS is diagnosed through a combination of hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology or elevated AMH, after other causes are excluded. In Ayurvedic assessment, PCOS presentations with delayed cycles, scanty cycles, anovulatory tendency, heaviness, weight gain, metabolic congestion, acne, hirsutism, or polycystic ovarian morphology are commonly read through Artavavaha Srotas with a dominant Sanga pattern. Sushruta’s Artavavaha Srotas is rooted in Garbhashaya and Artavavahi Dhamani, and injury or disturbance to this field is associated with infertility, amenorrhea, and dyspareunia.

The Dosha picture is not identical in every case. Kapha and Meda involvement are prominent where heaviness, lethargy, weight gain, insulin-resistance features, and congestion dominate. Apana Vata must also be assessed because Apana governs the downward movement of menstrual flow, and menstrual disorders are strongly linked with Apana disturbance. In lean or highly irregular presentations, Vata may be more visible, but even then the practical question remains whether Apana is obstructed, depleted, or moving irregularly.

The treatment direction is therefore not simply “give reproductive tonics.” In an obstructed Kapha-Meda-Ama presentation, the first principle is to clear Sanga, restore Agni, reduce channel-clogging habits, and regulate Apana Vata. Nourishing reproductive therapies are better placed after the channel has enough clarity to receive and transform them.

Endometriosis: Artavavaha Srotas Vimarga Gamana as a Clinical Analogy

Endometriosis is a modern medical condition in which endometrium-like tissue grows outside the uterus, causing inflammation, pain, scar tissue, heavy bleeding in some cases, infertility, bowel or bladder symptoms, fatigue, and mental health burden. Ayurveda does not describe endometriosis under that modern name, but the Srotovibhanga pattern of Vimarga gamana is a useful clinical lens because the defining feature is tissue and bleeding behaviour outside the usual uterine location.

In Ayurvedic reasoning, endometriosis-like presentations require careful attention to Apana Vata, Rakta, Pitta, pain, inflammation, adhesions, and the direction of pelvic flow. Where pain is severe, cyclical, stabbing, fixed, burning, or associated with heavy bleeding, the case should not be treated casually as ordinary menstrual discomfort. The treatment direction is to regulate Apana Vata, cool and protect Rakta-Pitta where indicated, reduce pelvic congestion, and integrate care with gynecological diagnosis and monitoring.

Hashimoto’s Thyroiditis and Hypothyroid Features: Rasa Vaha, Agni, Kapha-Meda and Galaganda When Swelling Is Present

The thyroid gland is not listed as a separate named Srotas in Charaka’s thirteen gross Srotas. Hashimoto’s thyroiditis is a modern autoimmune thyroid disorder and a common cause of hypothyroidism. Hypothyroid presentations can include fatigue, weight gain, cold intolerance, dry skin or hair changes, heavy or irregular periods, fertility difficulty, slowed heart rate, and depression. In Ayurvedic assessment, these symptoms often bring attention to Agni, Rasa Dhatu, Rasavaha Srotas, Medovaha Srotas, Kapha, Meda, and Vata according to the individual presentation.

When there is visible or palpable neck swelling, the classical comparison is Galaganda, a swelling in the neck region traditionally discussed with Vata, Kapha, and Meda involvement. This does not mean every hypothyroid patient has Galaganda, and it does not mean thyroid disease should be managed without laboratory testing. It means the classical language has a neck-swelling category for goitre-like presentations, while sluggish metabolism and tissue-nourishment signs are assessed through broader Agni, Rasa, Meda, and Srotas principles.

Depression, Brain Fog and Emotional Heaviness: Manovaha Srotas as a Connected Channel

Manovaha Srotas are described as channels through which mind and body interact, carrying thoughts, emotions, and psychological functions. They are not simply a “mental organ” separate from the rest of physiology. The Ayurvedic discussion of Manovaha connects it with Hridaya, Rasavaha Srotas, Rasa-Rakta circulation, Vata, Rajas, Tamas, and the quality of nourishment reaching the mind-body system.

This is why a woman with PCOS, hypothyroid features, poor digestion, heavy body, irregular cycles, and depression may feel fragmented in diagnosis but unified in lived experience. Rasavaha disturbance can affect nourishment, Medovaha disturbance can affect heaviness and metabolic flow, Artavavaha disturbance can affect menstrual rhythm, and Manovaha disturbance can affect mood and cognition. The integrated Ayurvedic question is: what is the shared channel pattern, and where should treatment begin so that the whole person becomes clearer, lighter, better nourished, and better regulated?

Identifying the Srotovibhanga Pattern: Practical Signs

The following table gives a practical clinical map. It is not a replacement for diagnosis, imaging, laboratory work, or a physician’s examination. It is a way to recognize the form of channel disturbance that may be operating behind a woman’s symptoms.

The Treatment Approach by Vibhanga Type

Srotovibhanga treatment begins with pattern recognition rather than disease-name matching. A formulation that helps one woman may aggravate another if the channel pattern, Dosha, Agni, strength, pregnancy status, bleeding status, and conventional diagnosis are not assessed.

For Sanga, especially in PCOS-like delayed cycles, sluggish metabolism, constipation, and Kapha-Meda presentations:

• Begin with Agni assessment. If digestion is dull and Ama signs are present, Deepana-Pachana and lightening measures come before heavy tonics.
• Reduce channel-clogging inputs such as excessive heavy, cold, overly unctuous, sweet, sedentary, and day-sleep-promoting habits when these match the patient’s constitution and condition.
• Regulate Apana Vata through routine, bowel regularity, warm food, pelvic care, stress reduction, and physician-guided therapies when menstrual flow is delayed or painful.
• Use Shodhana only under qualified supervision, especially when Vamana, Virechana, Basti, or Uttarabasti are being considered.

For Atipravritti, especially heavy menstrual bleeding or excessive discharge:

• Assess strength, hemoglobin status, bleeding severity, cycle pattern, pregnancy possibility, thyroid function, and gynecological causes.
• When Pitta-Rakta signs dominate, the direction is cooling, stabilizing, and protecting tissue strength while addressing the cause of excess flow.
• Classical management of excessive menstrual bleeding includes physician-guided Virechana and carefully chosen Rakta-stambhaka measures only when clinically appropriate.
• Heavy bleeding with dizziness, faintness, pregnancy, severe pain, anemia, or sudden change requires prompt medical care.

For Siragranthi, especially cysts, fibroids, nodules, and glandular swellings:

• Confirm the structure with appropriate imaging or examination rather than assuming every swelling is the same type of Granthi.
• Assess whether the background is Kapha-Meda accumulation, Vata constriction, Rakta-Pitta involvement, or a mixed pattern.
• Kanchanara Guggulu is traditionally used in Granthi, Apachi, Galaganda, Arbuda and related swelling patterns, but it should not be treated as a standalone cure for cysts, fibroids, thyroid nodules, or endometriosis.
• Monitor medically when a cyst, fibroid, thyroid nodule, breast lump, rapidly growing swelling, or unexplained mass is present.

For Vimarga Gamana, especially endometriosis-like pelvic pain and tissue mislocation patterns:

• Make Apana Vata regulation central: downward movement, bowel rhythm, pelvic relaxation, and reduction of Vata-aggravating strain are essential.
• Assess Rakta-Pitta signs such as burning pain, heat, inflammation, heavy bleeding, irritability, and red or dark bleeding patterns.
• Use Basti, Uttarabasti, Rakta-Pitta therapies, or strong herbal protocols only under qualified Ayurvedic physician supervision.
• Integrate care with gynecology, especially when pain is severe, fertility is affected, bowel or bladder symptoms occur, or imaging suggests endometriosis, cysts, fibroids, or adhesions.

Related reading: Ayurvedic ovarian cyst management, our complete guide to endometriosis stage-by-stage Ayurvedic protocol, and Sapta Dhatu nourishment sequentially.

Safety: This article describes Ayurvedic pathophysiology for educational purposes. PCOS, endometriosis, ovarian cysts, fibroids, thyroid disease, depression, infertility, heavy bleeding, pregnancy-related symptoms, and pelvic pain require evaluation by a qualified healthcare provider. Ayurvedic treatment, Panchakarma, Kanchanara Guggulu, uterine therapies, and strong herbal protocols should be used only under a qualified Ayurvedic physician and should be integrated with, not substituted for, appropriate conventional care.

References

1. Charaka Samhita — Sroto Vimana
2. Monash (monash.edu)
3. Jaims (jaims.in)
4. Charaka Samhita — Menstrual disorders
5. World Health Organization
6. NIDDK
7. Jaims (jaims.in)
8. Charaka Samhita — Manovaha srotas
9. Easyayurveda (easyayurveda.com)
10. Hopkinsmedicine (hopkinsmedicine.org)
11. NCCIH

The eight questions below are a practical clinical synthesis for organizing that examination. They should not be presented as a verbatim classical list called “the eight Samprapti Ghatakas.” Classical texts discuss samprapti, its varieties, the stages of dosha progression, affected dosha and dushya, srotas, agni, disease pathways, place, time, and patient strength in several different contexts. Contemporary Ayurvedic teaching often gathers these factors into a working samprapti-ghataka chart, but the exact number and headings vary.

What Is Samprapti?

Samprapti means pathogenesis: the process through which disturbed dosha participate in the origin and full manifestation of disease. It is one of the five diagnostic limbs of Nidana Panchaka, together with causative factors, prodromal features, manifested signs and symptoms, and factors that relieve or aggravate the condition. Charaka’s diagnostic tradition also classifies samprapti by number, predominance, prognosis or type, proportional dosha involvement, strength, and time.

Shat Kriya Kala is related but not identical. It is the six-stage temporal account described in Sushruta Samhita, Sutrasthana chapter 21:

1. Sanchaya — accumulation of a dosha in its own principal site
2. Prakopa — further aggravation of the accumulated dosha
3. Prasara — spread beyond its principal site
4. Sthana Samshraya — localization where dosha and susceptible dushya interact
5. Vyakti — recognizable manifestation of disease
6. Bheda — differentiation, chronicity, or complications

Kriya Kala answers “at what stage can intervention occur?” A samprapti analysis answers “which factors are participating, where are they acting, how strong is the process, and what can this patient safely tolerate?” The two frameworks complement one another but should not be attributed to the same verse or treated as interchangeable.

Eight Clinical Questions for Mapping Samprapti

The following questions preserve the useful bedside structure of the original article while separating disease factors from patient-examination factors. They are an interpretive clinical framework grounded in classical categories, not a newly invented classical quotation.

1. Dosha and Guna — What Is Disturbed?

The first task is not to label the person simply “Vata,” “Pitta,” or “Kapha.” The physician examines which dosha are involved in the present disorder, their relative predominance, their sites and subtypes where clinically relevant, and the qualities expressed in the symptoms. Dryness, mobility, irregularity, heat, sharpness, heaviness, coldness, stickiness, and stability may be more useful than a broad constitutional label because treatment follows the qualities actually increased.

In a person with rheumatoid arthritis, pain, swelling, warmth, stiffness, fluctuation, appetite, bowel pattern, sleep, fatigue, and response to heat or cold must be recorded rather than inferred from the biomedical diagnosis. Joint erosion cannot accurately be declared “Pitta-mediated,” and a Kapha constitution cannot be said to have “allowed the disease to settle” without a full examination. Those are hypotheses, not established classical or biomedical facts.

2. Dushya — What Has Become Susceptible or Affected?

Dushya denotes the body constituents that are vitiated by disturbed dosha, especially dhatu and mala. The seven structural dhatu are rasa, rakta, mamsa, meda, asthi, majja, and shukra; the relevant dushya must be inferred from the patient’s signs and the classical disease pattern rather than assigned from a laboratory mechanism alone.

For joint disease, asthi and sandhi are clinically important sites, and associated involvement of mamsa, meda, rakta, or other constituents may be considered when supported by findings. It is not valid to designate majja as a dushya merely because modern immune cells arise from bone marrow. Classical majja dhatu and the biomedical hematopoietic system are not interchangeable concepts. Likewise, Shallaki, Ashwagandha, or mineral supplements should not be prescribed automatically as “Asthi nutrition”; medicine selection requires a separate assessment of indication, formulation, dose, safety, and interaction risk.

3. Srotas and Srotodushti — Which Transport Systems and Disturbances Are Present?

Srotas are channels or systems of transport and transformation. Charaka describes roots and signs of disturbance for major srotas and gives four broad patterns of srotodushti: excessive flow or activity (atipravritti), obstruction or reduced flow (sanga), abnormal thickening or nodular change (siragranthi), and movement through an improper pathway (vimarga gamana). A useful chart therefore records not only the named srotas but also the type of dysfunction observed.

Because Charaka includes bones and joints within the madhyama rogamarga, that pathway is relevant when analyzing chronic articular disease. This does not automatically make Sneha Basti, Pizhichil, or any other procedure the primary treatment. Route and procedure must be selected only after determining dosha state, presence or absence of ama, bowel status, disease and patient strength, contraindications, and concurrent medicines.

4. Agni and Ama — Can the Patient Digest Food and Treatment Appropriately?

Agni denotes factors responsible for digestion, transformation, and metabolism. Charaka describes four functional states: sama (balanced), vishama (irregular), tikshna (intense), and manda (reduced). Assessment is based on appetite, digestion, tolerance of quantity and timing, bowel pattern, post-meal symptoms, and related clinical findings. The label should not be assigned from body type alone.

Ama is an Ayurvedic pathological concept associated with impaired digestion or transformation; it is not a synonym for “toxins,” CRP, immune complexes, or any single measurable biomedical substance. In practice, the physician should document the signs used to infer sama or nirama states rather than asserting that ama initiates most diseases. Strong fasting, concentrated spices, internal oleation, or purification can all be inappropriate when chosen without regard to appetite, hydration, medication effects, liver and kidney status, and overall strength.

5. Udbhava Sthana, Adhisthana, and Rogamarga — Where Did the Process Arise and Where Is It Expressed?

A precise samprapti distinguishes the suspected site of origin (udbhava sthana), the route or pathway of progression, and the principal site of manifestation (adhisthana or vyakti sthana). Classical rogamarga are broadly described as internal or koshtha, external or shakha, and madhyama, which includes vital structures, bones, and joints. These categories are more defensible than dividing the body into simplistic “Kapha upper,” “Pitta middle,” and “Vata lower” zones and then assigning one cleansing procedure to each zone.

In the illustrative case, the joints are an evident site of manifestation, but the origin and sequence cannot be reconstructed from anti-CCP positivity or X-rays alone. History must explore digestion, onset, preceding illness, symptom chronology, bowel changes, constitutional tendencies, aggravating exposures, and the order in which systemic and joint features appeared.

6. Roga Bala — How Strong and Advanced Is the Disease?

Disease strength is assessed from the power of causative factors, degree and number of dosha involved, dushya involvement, site, duration, complications, symptom burden, and resistance to treatment. Charaka warns that outward presentation may make a mild disease appear severe or a severe disease appear mild; the physician must therefore compare symptoms with objective examination and the course over time.

For rheumatoid arthritis, contemporary measures such as swollen and tender joint counts, inflammatory markers, functional limitation, imaging, and a rheumatologist’s disease-activity assessment remain important. Positive antibodies and erosions suggest clinically significant disease, but they do not by themselves establish an Ayurvedic Kriya Kala stage. Established erosive rheumatoid arthritis is already a manifested biomedical disease; calling it “Sthana Samshraya-Vyakti” adds little unless the Ayurvedic reasoning and observed signs are explicitly documented.

7. Rogi Bala and Prakriti — What Can This Patient Safely Tolerate?

Patient strength is not adequately captured by age or constitution. Charaka’s tenfold patient examination considers prakriti, vikriti, sara, samhanana, pramana, satmya, sattva, capacity to take and digest food, exercise capacity, and age. Desha is considered separately in assessing morbidity and planning treatment. These findings help classify strength and guide the intensity, dose, route, and timing of treatment. Prakriti is one part of this examination, not the final “synthesizing ghataka” of a fixed eight-part samprapti list.

Classical bala is also described as sahaja (constitutional), kalaja (influenced by age and season), and yuktikrita (acquired through suitable diet, activity, rest, and other measures). A patient taking methotrexate is not automatically depleted, and “Rasayana preparation before Shodhana” is not a universal rule. Actual fatigue, weight change, anemia, infection history, liver and kidney tests, exercise tolerance, nourishment, sleep, and mental resilience are more useful than assumptions based on medication duration.

8. Kala and Desha — When and in What Environment Is the Disease Being Treated?

Kala includes season, age, disease duration and stage, timing of aggravation, and appropriate timing of medicines or procedures. Desha includes habitat as well as features of the patient’s body. Climate can influence comfort, appetite, activity, and symptom aggravation, but treatment should not be reduced to “Chennai means cooling” or “Shimla means warming.” The patient’s actual response to weather is more important than a city label.

Classical seasonal patterns describe natural accumulation, aggravation, and pacification of dosha; for example, Vata is described as aggravated in the rainy season, Pitta in autumn, and Kapha in spring. These are general guides, not guarantees that every person with arthritis worsens in monsoon and winter. Likewise, the commonly taught daily dosha periods are broad rhythmic observations and should not be represented as proof that treatment administered within a particular four-hour window necessarily produces superior clinical outcomes.

Applying the Framework to the Illustrative Case

A corrected chart records what is known, what requires examination, and what cannot be inferred. It should guide questions rather than manufacture certainty.

The result is individualized without claiming that Ayurveda can decode rheumatoid factor, anti-CCP antibodies, marrow immunology, or radiographic erosion into one-to-one classical categories. Individualization means disciplined observation and proportionate treatment, not attaching a dosha label to every biomedical finding.

For the broader doshic assessment process that feeds into this analysis, see our clinical guide to identifying disturbed dosha. For decisions about cleansing procedures, see when NOT to do Panchakarma. These resources should be used as educational material, not as substitutes for examination.

Safety in Rheumatoid Arthritis

Rheumatoid arthritis is a potentially disabling inflammatory disease for which disease-modifying treatment is used to control activity and limit damage. A person with persistent symptoms while taking methotrexate should discuss disease activity and treatment targets with the rheumatologist rather than reducing, stopping, or replacing the medicine independently. Methotrexate requires periodic blood-count, liver-function, and kidney-function monitoring according to the treating clinician’s protocol.

Any Ayurvedic medicine or procedure should be disclosed to the rheumatologist and pharmacist. Herbal, mineral, and herbo-mineral products may interact with medicines or add hepatic, renal, hematologic, or contamination risks. Product identity and quality matter, and some Ayurvedic preparations have been found to contain toxic amounts of lead, mercury, or arsenic. Adjunctive care should therefore use traceable products prescribed by a qualified practitioner and should include monitoring appropriate to the patient’s medicines and medical history.

Disclaimer: This article is an educational explanation of Ayurvedic diagnostic reasoning. It is not a treatment protocol and should not be used to self-diagnose, self-prescribe herbs, undertake Panchakarma, or alter rheumatoid arthritis medication. Consult a qualified Ayurvedic physician and coordinate all adjunctive care with a rheumatologist or other licensed healthcare provider.

Verified References

The following sources support the corrected classical framework and the modern safety statements used above.

• National Institute of Indian Medical Heritage. e-Charaka Samhita.
• National Institute of Indian Medical Heritage. e-Sushruta Samhita, Sutrasthana chapter 21.
• Charak Samhita Research, Training and Skill Development Centre. “Samprapti,” “Sroto Vimana,” “Roganika Vimana,” and “Rogabhishagjitiya Vimana.”
• Fraenkel L, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research. 2021.
• Specialist Pharmacy Service, NHS. Methotrexate monitoring guidance.
• National Center for Complementary and Integrative Health. Ayurvedic Medicine: In Depth.

References

1. Charaka Samhita — Samprapti
2. Charaka Samhita — Nidana Sthana
3. Niimh (niimh.nic.in)
4. Niimh (niimh.nic.in)
5. Ayushdhara (ayushdhara.in)
6. Charaka Samhita — Dosha
7. Charaka Samhita — Dhatu
8. Charaka Samhita — Majja dhatu
9. Charaka Samhita — Sroto Vimana
10. Charaka Samhita — Rogamarga
11. Charaka Samhita — Roganika Vimana Adhyaya
12. Charaka Samhita — Agni
13. Charaka Samhita — Rogabhishagjitiya Vimana
14. Charaka Samhita — Tistraishaniya Adhyaya
15. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis (2021), PubMed Central
16. Sps (sps.nhs.uk)
17. NCCIH

IBS is defined biomedically by a recurring pattern of abdominal pain associated with altered bowel movements; constipation, diarrhea, or both may occur without visible damage in the digestive tract. Ayurveda does not replace that diagnosis, but it can organize a second line of inquiry: what factors preceded the illness, what warning signs appeared, what is now fully manifest, what reliably relieves or aggravates it, and how the disorder may have developed. This five-part inquiry is called Nidana Panchaka.

What Nidana Panchaka Means

Charaka Samhita, Nidana Sthana 1.6, states that a disease is understood through nidana (etiological factors), purvarupa (premonitory features), linga or rupa (manifest signs and symptoms), upashaya (relieving or pacifying factors), and samprapti (pathogenesis). These are not five competing diagnoses. They are five complementary ways of examining one illness so that the clinician does not treat a symptom in isolation.

Component 1: Nidana (Etiological Factors)

Nidana means a cause or etiological factor. In Nidana Sthana 1.3, Charaka gives a broad threefold account of causation: asatmyendriyartha-samyoga, unsuitable use or contact of the senses with their objects; prajnaparadha, errors of judgment, restraint, or memory expressed through mind, speech, or action; and parinama or kala, temporal factors such as season and change over time. These categories should not be reduced to simplistic labels for every modern habit.

For digestive disorders, the classical history is more specific. Grahani Chikitsa 15.42-43 lists fasting, eating during indigestion, overeating, irregular eating, unsuitable food, excessively heavy, cold, dry, or contaminated food, disturbance related to place, time, or season, and suppression of natural urges among factors that impair agni. Therefore, the engineer’s changed meal timing, unfamiliar diet, environmental change, and disrupted routine would be clinically relevant history. They would be investigated as possible contributors, not declared proven causes merely because they occurred before symptoms.

Identifying nidana has a practical purpose. Ayurvedic management emphasizes nidana-parivarjana, avoidance or correction of causative and aggravating factors. In a real IBS case, that may mean regularizing meals and sleep, identifying reproducible food triggers, and reducing an ongoing source of strain while medical care continues. It does not mean stopping prescribed medicine or assuming that lifestyle change alone will cure every patient.

Component 2: Purvarupa (Premonitory Features)

Purvarupa are features appearing before the disease is fully expressed; Charaka defines them this way in Nidana Sthana 1.8. They are disease-specific classical observations, not a synonym for every modern risk factor or laboratory abnormality. For example, the text lists altered taste, heaviness, aversion to food, yawning, shivering, fatigue, anorexia, and indigestion among the premonitory features of jwara. In Grahani Chikitsa 15.55, thirst, malaise, diminished strength, burning, delayed digestion, and bodily heaviness are listed before fully developed grahani-gada.

The clinical value of purvarupa is careful chronology. A practitioner asks what appeared first, which features were mild or intermittent, and whether they preceded the current pattern. In the illustrative case, irregular appetite and episodic bloating before persistent bowel disturbance would belong in that timeline. Such observations may guide an Ayurvedic assessment, but they do not replace testing when anemia, bleeding, weight loss, fever, persistent vomiting, or another concerning feature is present.

Component 3: Rupa (Manifest Signs and Symptoms)

Rupa or linga refers to signs and symptoms after they have become manifest, as defined in Nidana Sthana 1.9. This includes what the patient experiences and what the clinician observes. In biomedical IBS assessment, the essential pattern includes abdominal pain related to bowel movements plus changes in stool frequency or form. The bowel pattern may involve constipation, diarrhea, or both.

Ayurvedic texts describe dosha-patterned presentations of grahani, but grahani should not be treated as a one-to-one synonym for IBS. In Grahani Chikitsa 15.60-64, the vatika presentation includes abdominal distension, difficult or delayed evacuation, flatus, and stools that may be dry, small, loose, or mixed with undigested material. Verses 65-66 describe pittaja features such as loose stool, sour or foul eructation, burning, anorexia, and thirst. Verses 67-70 describe kaphaja features including difficult digestion, nausea, heaviness, mucus or undigested material in stool, weakness, and lassitude. These descriptions can inform pattern recognition, but they do not replace a gastroenterological differential diagnosis.

Component 4: Upashaya (Relieving and Aggravating Factors)

Charaka defines upashaya in Nidana Sthana 1.10 as the beneficial response produced by medicines, food, or regimen that counter the cause or disease directly or indirectly. Anupashaya denotes factors associated with aggravation rather than relief. Thus, response to a carefully chosen intervention can contribute to assessment, especially when the nature of a disorder is not immediately clear.

In practice, this can begin with a symptom diary rather than an aggressive “therapeutic test.” The patient records meals, stool form, pain, sleep, stress, and the timing of relief or worsening. A reproducible response to a consistent meal pattern or a particular food may be useful information, but one episode proves little. Deliberately provoking severe symptoms, fasting excessively, taking unknown herbs, or using cleansing procedures as a home diagnostic experiment is unsafe.

Component 5: Samprapti (Pathogenesis)

Samprapti is the account of disease development. Charaka’s Nidana Sthana 1.11-12 discusses samprapti and classifies it by number, dosha predominance, type, proportional involvement of doshas and their qualities, strength, and time. The familiar six-stage model is not a sixfold samprapti stated by Charaka; it is shat-kriyakala, described in the Sushruta tradition as stages of dosha vitiation and disease progression.

This sequence is an Ayurvedic explanatory and therapeutic model, not a validated biomarker ladder and not proof that conventional medicine acts only after full manifestation. Its proper use is to clarify the clinician’s hypothesis: which dosha and qualities are involved, which tissues or channels are affected, where the process is situated, what maintains it, and which part of the sequence can be interrupted safely.

Applying Nidana Panchaka to the Illustrative IBS Case

The case can now be organized without pretending that IBS and grahani are identical:

• Nidana: Irregular meals, altered food pattern, sleep disruption, work strain, and change of place or climate are investigated as possible aggravating factors.
• Purvarupa: Early irregular appetite and intermittent bloating establish the chronology but do not independently diagnose the disorder.
• Rupa: Abdominal pain, gas, and altered stool are documented precisely, while the biomedical bowel pattern and alarm features are reviewed.
• Upashaya and anupashaya: Reproducible responses to foods, routines, and prescribed treatment are recorded rather than guessed.
• Samprapti: A qualified practitioner formulates an Ayurvedic explanation involving agni, dosha, site, and affected factors, then revises it according to response and new evidence.

A responsible plan would preserve the gastroenterologist’s diagnosis and monitoring, correct modifiable routine factors, and individualize diet. Current gastroenterology guidance supports a limited trial of a low-FODMAP diet for some people with IBS, ideally followed by structured reintroduction and personalization rather than indefinite restriction. Ayurvedic herbs are not selected merely because symptoms sound “Vata-like,” and basti or other Panchakarma procedures should never be self-administered. Their suitability depends on examination, disease stage, strength, digestion, contraindications, and professional supervision.

For a deeper explanation of dosha assessment, see our guide on doshic imbalance assessment. For the digestive and mind-body context, see the gut-brain axis in Ayurveda. These educational articles should be used alongside, not instead of, appropriate medical evaluation.

References

1. NIDDK
2. NIDDK
3. Charaka Samhita — Jwara Nidana
4. Charaka Samhita — Grahani Chikitsa
5. Niimh (niimh.nic.in)
6. ACG Clinical Guideline: Management of Irritable Bowel Syndrome (2021), PubMed
7. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review (2022), PubMed